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Abstract
Sarcomatoid hepatocellular carcinoma (HCC) is a very rare histologic variant of HCC. The characteristic of skeletal 
metastatic sarcomatoid hepatocellular carcinoma has never been reported. We reported a patient with sarcomatoid 
hepatocellular carcinoma pelvic metastasis who presented with huge pelvic metastasis that had relatively small 
osteolytic lesion centrally located accompanied by huge bipeduncular invasive expansile lesions into surrounding soft 
tissue. The lesion showed almost non-isotope uptake in 99mTc-methylene diphosphonate bone scintigraphy study. He 
underwent radiotherapy and tumor excision but the tumor rapidly recurred. In addition, serum α-fetoprotein level was 
never elevated beyond normal limit (< 20 ng/mL) through the whole course of treatment. We considered sarcomatoid 
hepatocellular carcinoma bone metastasis a highly aggressive lesion with unusual metastatic pattern. Surgical 
treatment with adequate safe margin in such a huge tumor with hypervascularity and extensive invasion in the pelvis 
was difficult; and radiotherapy maybe refractory regarding the sarcomatous nature. Therefore, debulking operation 
with local symptoms control may provide a better quality of life. And the clinical course suggests sarcomatoid 
hepatocellular carcinoma is derived from the transition of an ordinary hepatocellular carcinoma.
Introduction
Sarcomatoid hepatocellular carcinoma (HCC) is a very
rare histologic variant of HCC with an incidence of 1.8%
in surgically resected cases and 3.9% to 9.4% in autopsied
cases [1-4]. Although sarcomatous transformation of
HCC had been discussed in a few reports [3,5]; it was
never been reported in patients with bone metastasis.
The skeletal metastasis of sarcomatoid HCC have spe-
cific features of expansile, destructive nature, accompa-
nied by large, bulky soft tissue masses; and these lesions
often showed non-isotope uptake in 99mTc-methylene
diphosphonate (MDP) bone scintigraphy (BS) study [4,6-
8].
We report a patient with sarcomatoid HCC pelvic
metastasis. The patient presented with huge pelvic
metastasis that had relatively small osteolytic lesion cen-
trally located accompanied by huge bipeduncular inva-
sive expansile lesions into surrounding soft tissue. He
underwent radiotherapy and tumor excision. Unfortu-
nately, the tumor rapidly recurred in short period. On the
other hand, serum α-fetoprotein (AFP) level was never
elevated beyond normal limit (< 20 ng/mL) after diagno-
sis of skeletal metastasis.
Case Report
The patient was a 61 year-old male, who was a hepatitis B
virus (HBV) carrier. He had hepatoma since November
2006 and underwent right hepatectomy. Pathologic anal-
ysis showed typical grade II to III HCC. Serum AFP level
was greater than 3,000 ng/mL at that time. Abdominal
sonography in July 2008 did not detect any viable liver
tumor. However, hepatic tumor recurrence was noted
since November 2008 and was treated 3 times with tran-
sarterial embolization (TAE) therapy from November
2008 to July 2009.
On the other hand, a solitary right pelvic HCC metasta-
sis was noted since July 2008; and was treated with pallia-
tive radiotherapy by a total dose of 5,250 cGy in 21
fractions from August 2008 to March 2009. The discom-
fort subsided temporarily after radiotherapy treatment.
Unfortunately, the patient had progressive right low back
pain with radiation to right lower extremity accompanied
with right buttock knocking pain since 2009 April, and
the symptom deteriorated in the following few weeks.
Pelvis radiograph showed a large osteolytic lesion by right
iliac bone near sacroiliac junction (Fig 1-A; white arrows).
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Figure 1 Pelvis radiograph showed a large osteolytic lesion over right iliac bone near sacroiliac junction (white arrows) (A). MRI revealed a 
9.6 × 9.4 × 9.0 cm bilobular huge tumor mass arising from right iliac wing with bony destruction and significant soft tissue extension (white arrows) 
(B to E). 99mTc-MDP BS showed mildly hot areas at right iliac bone with a large, round cold area (black arrows) (F). B: axial T1-weighted image with 
contrast enhancement. C: axial T2-weighted image. D: coronal fat-suppressed (FS) T2-weighted image with contrast enhancement. E: coronal short 
tau inversion recovery (STIR) images.
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9.4 × 9.0 cm bilobular lesion arising from right iliac bone
with heterogeneity and good enhancement after contrast
(Fig 1-B to 1-E, white arrows). Bony destruction into adja-
cent sacrum and significant soft tissue extension were
also noted, causing adjacent psoas, iliacus and gluteus
muscles hyperemia. Besides, tumor compression of the
right sciatic nerve was also suspected. 99mTc-MDP BS
showed mildly hot areas at right iliac bone with a large,
round cold area (Fig 1-F; black arrows).
The patient underwent tumor excision on June 8th,
2009. A hypervascular round mass about 10 cm in diame-
ter located at right iliac wing was noted intraoperatively.
The tumor had a relatively small central bony destruction
about 2.5 × 2.0 cm in size and expanded into both inner
and outer sides of the pelvic wall. These findings sug-
gested that the whole tumor mass originated from a cen-
tral bone metastasis and then gradually enlarged and
invaded into soft tissue in both directions. The histo-
pathological examination with Hematoxylin and Eosin
(H&E) staining showed tumor cells infiltrate in the bony
trabeculae and soft tissue. There were two patterns of
tumor cells (Fig 2A and 2-E). The carcinomatous tumor
cells with pleomorphic nuclei and abundant cytoplasm
arranged in solid sheets and nests were positive for hepa-
tocyte paraffin-1 (HepPar-1) staining (Fig 2-B) and cytok-
eratin-7 (CK7) staining (Fig 2-C). The carcinomatous
tumor cells also demonstrated sinusoidal vascular stroma
highlighted by CD34 (Fig 2-D). The other sarcomatous
cells with little cytoplasm arranged in the myxo-chon-
droid background were positive for vimentin, smooth
muscle actin (SMA), and S-100 protein staining (Fig 2-F
to 2-H). These features were compatible with a metastatic
HCC with sarcomatous change. The symptoms amelio-
rated gradually after operation and he could walk with
stick. Since the patient underwent radiotherapy before
this operation, no further radiotherapy was arranged.
However, bilateral lung metastases were diagnosed since
July 23rd, 2009 during follow up.
Unfortunately, another episode of right low back pain
occurred since mid-September 2009. The pain was more
severe compared with last time, especially when the
patient ambulated. Follow up pelvic radiograph showed a
large ill-defined osteolytic lesion at right iliac bone
accompanied with iliac wing fracture (Fig 3-A; white
arrows). Repeated MRI revealed a huge mass of 9.4 × 9.2
× 9.0 cm bipeduncular lesion arising from previous oper-
ation site, accompanied with iliac wing fracture (Fig 3-B
to 3-D, white arrows). Tumor recurrence was impressed
and the patient underwent tumor excision again on Octo-
ber 20th, 2009. Like previous operation, the tumor was
very hypervascular with approximate 9 cm in diameter;
Figure 2 Histopathologic pictures of the metastatic HCC. Hematoxylin and Eosin (H&E) staining showed tumor cells infiltrate in the bony trabec-
ulae and soft tissue (A and E). There were two patterns of tumor cells (A and E). Histopathologic pictures of the metastatic HCC. Hematoxylin and Eosin 
(H&E) staining showed tumor cells infiltrate in the bony trabeculae and soft tissue (A and E). There were two patterns of tumor cells (A and E). The 
carcinomatous tumor cells with pleomorphic nuclei and abundant cytoplasm arranged in solid sheets and nests were positive for HepPar-1 and cy-
tokeratin-7 (CK7) staining (B and C). The carcinomatous tumor cells also demonstrate sinusoidal vascular stroma highlighted by CD34 (D). The other 
sarcomatous cells with little cytoplasm arranged in the myxo-chondroid background were positive for vimentin, SMA, and S-100 protein staining (F 
to H). These features are compatible with a metastatic hepatocellular carcinoma with sarcomatous change. Magnification: 200×.
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pathological examination was compatible with earlier
one. Compared with last report, the whole pictures were
conclusive of progressive loss of hepatocytic carcinoma-
tous characters and transitional to the differentiation of
sarcomatous characters that included spindle cell, chon-
droid and osteoid components.
Since July 2008, serum AFP level was always within
normal limit (< 20 ng/mL). Even with large bone lesions
and systemic disease spreading, serum AFP level before
each operation was only 13.92 and 15.39 ng/mL respec-
tively.
Discussion
Hepatocellular carcinoma with a spindle cell component
has been referred to as sarcomatoid or sarcomatous
HCC, spindle cell carcinoma, pseudosarcoma, and carci-
nosarcoma [3]. According to previous reports, 2% to 27%
Figure 3 Pelvis radiograph showed a large ill-defined osteolytic lesion at right iliac bone accompanied with iliac wing fracture (white ar-
rows) (A). Repeated MRI revealed a 9.4 × 9.2 × 9.0 cm bipeduncular lesion arising from previous operation site, accompanied with iliac wing fracture 
(white arrows) (B to D). B: axial fast spin echo (FSE) fat-suppressed T1-weighted image with contrast enhancement. C: axial fast recover fast spin echo 
(frFSE) T2-weighted image. D: coronal fat-suppressed (FS) FSE T2-weighted image with contrast enhancement.
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dence is increasing with the use of more aggressive treat-
ments [2,9].
The pathogenesis of the sarcomatous appearance of
HCC has not yet been clarified because of a debate on
whether it is derived from the transition of an ordinary
HCC to a sarcomatous appearance or it is a double cancer
of HCC and hepatic sarcoma [2,3,5,10]. Most investiga-
tors thought that the sarcomatous component is derived
from a dedifferentiation of anaplasia from an ordinary
HCC rather than double cancer [1,5]. Our pathologic
analyses showed two patterns of tumor cells and the clin-
ical course also suggested dedifferentiation of a meta-
static HCC with sarcomatous change.
The typical findings of sarcomatoid HCC of liver is
reported to be of massive expanding or multinodular
confluent type with partial encapsulation [5]. Intrahe-
patic metastasis and adjacent organ invasion were rela-
tively more common with sarcomatoid HCC than with
ordinary HCC [11]. The metastatic lesions of our patient
presented with bulky expansile dumbbell-shaped soft tis-
sue masses, with relatively small bony destruction located
at central portion; and often showed cold lesions on
99mTc-MDP BS [4,6-8]. These characteristics suggested
that the lesions originated from skeleton and gradually
expanded as soft tumor masses almost without any bone
related activity [4,6-8,12]. To our knowledge, only one
previous report had metastatic HCC presented as sar-
coma-like change with peritoneal dissemination [13].
Actually, the larger soft-tissue portion of the metastasis
behaved more like a sarcoma.
Radiation induced sarcoma is a rare sequela of radiation
therapy, and often occurred more than 10 years after
radiotherapy [14,15]. The radiation dose in patients with
radiation induced sarcoma is usually greater than 3,000
cGy [14]. Although we have no direct evidence that this
sarcomatous change was associated with radiotherapy,
but our patient received 5,250 cGy radiation and primary
hepatic lesion revealed a typical HCC. These findings
suggested the possibility of radiation induced sarcoma-
tous transformation of HCC, although the interval
between radiation and sarcomatous transformation in the
case herein presented is a few months rather than the
expected duration greater than 10 years.
On the other hand, serum AFP level never exceeded
normal limit (< 20 ng/mL) in our patient since diagnosis
of bone metastasis. Even with large tumor burden before
both bone tumor excisions, the highest recorded serum
AFP level was 15.39 ng/mL. This finding was compatible
with the 11-patient series by Koo HR et al [5]. In their
series, serum AFP level was more than 20 ng/mL in 7
patients (64%) and was more than 500 ng/mL in only 1
patient (9%).
In conclusion, we considered sarcomatoid HCC bone
metastasis a highly aggressive lesion with unusual meta-
static pattern. Surgical treatment with adequate safe mar-
gin in such a huge tumor with hypervascularity and
extensive invasion in the pelvis was difficult; and radio-
therapy maybe refractory regarding the sarcomatous
nature. Therefore, debulking operation with local symp-
toms control may provide a better quality of life. 99mTc-
MDP BS often has false-negative results and serum AFP
level is not an appropriate marker for monitoring of bone
metastasis of sarcomatoid HCC. Besides, the clinical
course suggests sarcomatoid HCC is derived from the
transition of an ordinary HCC.
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